Bayer Backs Vesigen To Improve Cell and Gene Therapy Delivery

New Biotech Approach For Gene Editing, mRNA

 
• By Andrew McConaghie

Serial entrepreneur Robert Millman is leading the new biotech which thinks it has the answer to getting CRISPR and RNA-based therapies into cells more efficiently

Kendall_Square
Vesigen has its headquarters in Kendall Square, the heart of Boston's biotech world.

More from Business

More from Scrip